Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
MRNA
Moderna
$28.48
Login to see Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Investors confidence is positive
Technical Indicators
5+ Days Up
Chart
$24.47 (+16.39%)
$32.92 (-13.49%)
$24.07 (+18.32%)
$54.1 (-47.36%)
MRNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
MRNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Has a weak balance sheet
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MRNA Street view is extremely bullish but have mixed views on the near-term outlook
Average key support and resistance price levels.
Login to displayMRNA Earnings
The TTM reflects 12-month period, providing review of MRNA financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is MRNA current stock price?
What are MRNA stock strengths?
What risks are associated with MRNA stock?
When is MRNA next earnings report?
What is MRNA market cap and volume?
What is MRNA's current Stock IQ?
Should I buy MRNA stock right now?
Is MRNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for MRNA?
What does a 'Strong Sell' rating mean for MRNA?
What factors influence MRNA's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
MRNA
Moderna
Current Price
$28.48
Stock Insights
Strengths
Earnings are forecast to grow
Investors confidence is positive
Technical Indicators
5+ Days Up
Login to unlock Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$24.47 (+16.39%)
$32.92 (-13.49%)
$24.07 (+18.32%)
$54.1 (-47.36%)
MRNA Analysts Opinion
MRNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Has a weak balance sheet
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MRNA Street view is extremely bullish but have mixed views on the near-term outlook
MRNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayMRNA Earnings
The TTM data reflects the most recent 12-month period, providing overview of MRNA financial performance.
MRNA Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
MRNA Latest Analysis
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average. When a stock breaks out above the 50-Day simple moving average good things could be on the horizon. How should investors react?
Thu Oct 2, 2025
Could MRNAs Upcoming Product Launches Reduce COVID Sales Dependency?. Moderna plans up to 10 product launches over four years aiming to cut reliance on fading COVID-19 vaccine sales.
Thu Oct 2, 2025
Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight. Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population |. DelveInsightAccording to DelveInsight'.s analysis the market for Lyme disease is anticipated to increase during the forecast period (2025–2034) owing to the launch of emerging therapies such as Valneva and Pfizer'.s VLA15 and Tarsus Pharmaceuticals'. TP-05 Moderna'.s mRNA-19
Wed Oct 1, 2025
2 Beaten-Down Stocks to Buy and Hold for a Decade. Key PointsSignificant pipeline progress in the next five years could jolt Modernas stock higher.
Tue Sep 30, 2025
Moderna (MRNA) Dips More Than Broader Market: What You Should Know. In the closing of the recent trading day Moderna (MRNA) stood at $24.61 denoting a -4.91% move from the preceding trading day.
Thu Sep 25, 2025
Moderna Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum - Slideshow.
Thu Sep 25, 2025
Modernas COVID-19 Vaccine Update Boosts Antibodies 16-Fold Data Shows. ) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine mRNA) which targets the LP.8.1 .The data from an ongoing Phase 4 clinical trial evaluating the safety tolerability and immunogenicity of the 2025-2026 formula of mNEXSPIKE showed on average greater than a 16-fold increase in neutralizing antibodies against the LP.8.1 variant in individuals 12 through 64 years of age
Tue Sep 23, 2025
Notable Friday Option Activity: MRNA NKE FLNC. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Moderna Inc (Symbol: MRNA) where a total volume of 117137 contracts has been traded thus far today a contract volume which is representative of approximately
Fri Sep 19, 2025
Whats Going On With Moderna Stock Wednesday?. ) shares are flat Wednesday morning after a nearly 5% surge on Tuesday. Here’.s what investors need to know..However that optimism could be tempered by a shifting regulatory landscape. Health and Human Services Secretary appointed several new members with vaccine-skeptical histories to the CDC'.s influential Advisory Committee on Immunization Practices. The committee ...
Wed Sep 17, 2025
Moderna Stock Is Moving Higher Tuesday: Heres Why. ) shares are up nearly 5% on Tuesday after the company announced positive preliminary immunogenicity data for its 2025-2026 Spikevax formula which targets the .Overall the data revealed that there was more than an eightfold increase in the formula’.s ability to counteract antibodies against the LP.8.1 variant in those aged 12 through 64 with at least one underlying condition ...
Tue Sep 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings